Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa randomized double-blind placebo-controlled study of oral BGC20-0134 in relapsing-remitting multiple sclerosis
2009-011585-28Phase 2Terminated
- Sponsor
- BTG
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in multiple sclerosis (MS) comparing BGC20-0134 with Placebo (2 arms). Started Jul 2009; status: terminated.
02
Drugs
BGC20-0134
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2009-011585-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011585-28.